Hydromorphone (Hydromorphone Hydrochloride) - Summary

HYDROMORPHONE SUMMARY

Hydromorphone hydrochloride tablets USP, 8 mg are supplied in tablet form for oral administration. Hydromorphone hydrochloride, a hydrogenated ketone of morphine, is a narcotic analgesic.

Hydromorphone hydrochloride tablets are indicated for the management of pain in patients where an opioid analgesic is appropriate.

HYDROMORPHONE NEWS HIGHLIGHTS

Published Studies Related to Hydromorphone

Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. [2008.07]

Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized Saline. [2008.03.19]

Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain. [2008.03]

Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol. [2008.01]

Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. [2008.01]

more>>

Clinical Trials Related to Hydromorphone

Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain [Completed]

Comparison of Side Effects of Morphine and Hydromorphone PCA [Completed]

Safety Study of Intravenous Hydromorphone Using Incremental 1mg Doses up to 2mg for Adult ED Patients [Active, not recruiting]

Safety and Tolerability of Long-Term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain [Completed]

An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg [Completed]

more>>